All News #Library
Biotech
Orexo Us Secures $8m Barda Funding For Ox390 Development
30 Sep 2025 //
PHARMAWEB
Orexo reports positive data for AmorphOX intranasal Vaccine
10 Apr 2025 //
PR NEWSWIRE
Orexo Enters Collaboration with Abera for Nasal Powder Vaccines
17 Dec 2024 //
PR NEWSWIRE
Orexo initiates feasibility studies of amorphOX with twovaccine companies
09 Jan 2023 //
PR NEWSWIRE

Market Place
Sourcing Support